Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by JohnnyUtah16on Sep 04, 2019 11:45am
57 Views
Post# 30094434

RE:RE:Meir's press releases

RE:RE:Meir's press releasesThese beaten up companies are down because they sell highly addictive opioids that are killing thousands of people a year and they are now getting sued into oblivion. But you think GUD should buy these companies and their best selling drugs (opioids), and take over where they left off. These opioid companies are going to get hammered with law suits for decades. Why the F would GUD want to be involved in that? GUD's main 4 drugs are Burinex, Probuphine, Movantik, and Neuragen. Two of those are used to help people addicted to Opioids, one is used to treat people with Opioid addiction and another to treat Opioid induced constipation. Does it sound like JG wants to sell Opioids and then sell treatment for Opioids at the same time, $hit some of you are stupid. That would be like a tobacco company selling both cigarettes and a pill to cure nicotine addiction. You can't sell yourself as one of Canada's leading pharma companies while killing the patients/customers you are also treating. Get them addicted, then treat them, rinse and repeat. This is my once a month visit to this board and as usual the idiots are running a muck.
Bullboard Posts